GlassScriptPhysician profile
Allison J Eness
NPI 1962490284
$1,850.69
in general payments reported to CMS, 2019-2025
21 companies · $347 in 2025
The $347 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $435 · 2022: $447 · 2023: $356 · 2024: $266 · 2025: $347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $969.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $968.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $647.67 | 2021-2024 | |
| Astellas Pharma US INC | $177.83 | 2022-2025 | Veozah, Myrbetriq |
| Biogen, INC. | $139.77 | 2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $137.61 | 2021-2025 | |
| Idorsia Pharmaceuticals US INC | $86.90 | 2022-2023 | Quviviq |
| Pfizer INC. | $75.84 | 2022-2024 | |
| Exeltis, USA INC. | $63.24 | 2023-2024 | Slynd |
| Octapharma USA, INC. | $58.49 | 2025 | Fibryga |
| Mayne Pharma Commercial LLC | $57.90 | 2022-2024 | |
| Hologic Sales and Service, LLC | $50.11 | 2023-2024 | Aptima, Myosure Tissue Removal Device, Thinprep 2000 Processor |
| Therapeuticsmd, INC. | $48.32 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $48.30 | 2022 | |
| Agile Therapeutics, INC. | $40.24 | 2021-2023 | Twirla |
| Sumitomo Pharma America, INC. | $37.78 | 2023-2025 | Myfembree |
| Merck Sharp & Dohme LLC | $35.19 | 2024-2025 | Gardasil 9, Gardasil |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $34.46 | 2022-2023 | Paragard T 380a |
| Myovant Sciences INC. | $30.18 | 2022 | |
| Medtronic, INC. | $27.82 | 2022 | |
| Exact Sciences Corporation | $25.53 | 2024 | Cologuard Collection Kit |
| Novo Nordisk INC | $16.28 | 2023 | Wegovy |
| Organon LLC | $11.23 | 2023 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Eness listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.